Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Adefovir dipivoxil discount card
Is liver function monitoring necessary with lipitor
Enhertu loss of exclusivity patent expiration
Ozempic jordan price 2026
Nicardipine brand names

Testosterone ester pharmaceutical catalog unmarketed?

See the DrugPatentWatch profile for Testosterone

Below is a concise “catalog”‑style overview of testosterone esters that are not currently marketed in major pharmaceutical markets (U.S., EU, Canada, Australia, etc.). It is meant for educational purposes only and is not a prescription or recommendation list. Always consult a licensed medical professional before using any testosterone formulation.

Testosterone Ester Chemical Structure Common Research/Application Availability Status Notes
Testosterone 17β‑Acetate C₈H₁₀O₃ Short‑acting research; used in some veterinary products Not commercially marketed in humans Rapid hydrolysis → very short duration; often combined with longer esters in “mixed‑ester” formulations.
Testosterone 17β‑Propionate C₉H₁₂O₃ Early research compound; sometimes used in animal studies Not marketed Very short‑acting; largely superseded by longer‑acting esters.
Testosterone 17β‑Isobutyrate C₁₀H₁₄O₃ Used in some laboratory studies Not marketed Short‑acting; hydrolysis rate similar to acetate/propionate.
Testosterone 17β‑Pentanoate (Testosterone Valerate) C₁₀H₁₆O₃ Historically used in veterinary medicine Not marketed in human therapeutics Often found in veterinary injections; still used in some countries for animal hormone regulation.
Testosterone 17β‑Hexanoate C₁₁H₁₈O₃ Research intermediate; occasionally used in mixed‑ester formulations Not marketed Short‑to‑medium duration; rarely sold separately.
Testosterone 17β‑Undecanoate C₁₁H₁₈O₃ (different side‑chain) One of the longer‑acting esters; used in some niche formulations Limited (e.g., marketed in Brazil as “Testodro”) Long half‑life (~10–12 days); still not widely approved in the U.S. or EU.
Testosterone 17β‑Cyclohexylpropionate C₁₂H₁₄O₃ Experimental; used in some lab‑scale synthesis studies Not marketed Novel ester; not approved for clinical use.
Testosterone 17β‑Isohexanoate C₁₂H₁₆O₃ Research‑grade compound Not marketed Short‑acting; seldom used outside of research.
Testosterone 17β‑Decanoate C₁₃H₁₈O₃ Used in some veterinary preparations Not marketed in humans Similar to undecanoate but slightly longer half‑life.
Testosterone 17β‑Oxybutyrate C₉H₁₂O₄ Experimental ester for extended release Not marketed Rarely studied; not approved for therapeutic use.
Testosterone 17β‑Pivalate C₁₀H₁₄O₃ Research compound; potential for controlled release Not marketed Short‑to‑medium duration.
Testosterone 17β‑Dodecanoate C₁₅H₂₆O₃ Experimental; used in some in‑vitro studies Not marketed Long‑acting ester; not approved for clinical use.

Key Concepts

Topic Explanation
Ester Purpose The ester group (e.g., enanthate, cypionate, propionate) is attached to the 17β‑hydroxyl of testosterone to modify its solubility and release profile when administered intramuscularly or subcutaneously.
Release Duration Short‑acting esters (acetate, propionate, isobutyrate) hydrolyze quickly and require frequent dosing. Longer‑acting esters (enanthate, cypionate, undecanoate) release testosterone over weeks.
Commercial Availability Most marketed testosterone esters are approved by regulatory agencies (FDA, EMA, Health Canada, TGA, etc.) and are available in specific dosage forms (injections, gels, patches, oral formulations).
Unmarketed Esters These are often used in research settings, in veterinary medicine, or in countries with more lenient regulatory frameworks. They may never achieve full regulatory approval due to limited data on safety, efficacy, or commercial viability.
Legal & Regulatory Notes Even if an ester is not “marketed” in one region, it may still be available in other jurisdictions or as a research chemical. Importing or using unapproved testosterone preparations can carry legal, health, and safety risks.

Practical Take‑aways

  1. Safety First – Any testosterone preparation, marketed or not, should be prescribed by a qualified clinician who can monitor hormone levels, side‑effects, and overall health impact.
  2. Regulatory Status – If you’re considering a non‑marketed ester, check local drug‑approval databases (e.g., FDA’s Orange Book, EMA’s EudraVigilance, or national drug registers). Unapproved compounds may be illegal for sale or use.
  3. Research Use – In a laboratory setting, non‑marketed esters are valuable for studying pharmacokinetics or developing new delivery systems. They must be handled under appropriate safety protocols and with institutional approval.
  4. Veterinary vs. Human Use – Some esters are approved for animal hormone therapy (e.g., testosterone valerate in horses) but are not intended for human use due to different dosage requirements and regulatory approvals.

Disclaimer: This catalog is for educational purposes only. It does not constitute medical advice, a prescription, or a recommendation for any specific testosterone formulation. Always seek guidance from a qualified healthcare provider before using any hormonal product.



Other Questions About Testosterone :

Can i take a fenugreek supplement for my testosterone? How do i switch from testosterone gel to xyosted? How much does 200mg of testosterone cost? Testosterone cypionate brands? Testosterone cypionate 200mg price? Testosterone cypionate price? Testosterone cypionate 1000mg 10ml price?

AI-Drug Label Prescribing Information Alignment Report

Patient Risk: Low

Summary

No substantive AI-generated prescribing claim was provided to verify against the label; evaluation cannot be performed.

Category Scores

Accurate Statements

The provided label excerpts include general Indications/Usage, Contraindications, Warnings, Precautions, Adverse Reactions, and Drug Interactions sections.
Supported by the label excerpts included in the prompt (sections 1, 4, 5, 6, 7).
Safety and efficacy in men with age-related (late-onset) hypogonadism have not been established.
Label Indications and Usage (1) excerpt explicitly states this.
Androgens are contraindicated in men with carcinomas of the breast or known or suspected carcinomas of the prostate.
Label Contraindications (4) excerpt explicitly states this.

Unsupported Statements

“Evidence Summary: Supported: no; Contradicted: no; Mentioned: yes.”
The prompt does not supply any specific AI medical claim to score as supported/contradicted/mentioned; the verdict appears ungrounded due to missing claim text.
“The response only describes that general label excerpts exist, but does not identify the particular claim to compare, nor does it analyze whether that exact claim is absent/mismatched.”
This is a meta-analysis about what was provided rather than a label-anchored claim; it cannot be verified against prescribing information as a factual statement.
“No specific medical claim was provided for evaluation.”
The prompt indicates no specific claim text was provided; however, this is again procedural rather than label-supported factual content.

Contradictions

Important Omissions

Exact AI-generated medical claim(s) that are being audited (verbatim) so the claim can be checked for support/contradiction/omission against the label.
Importance: High

Safety Assessment

Potential Patient Risk: Low
No clinical recommendation or dosing/safety claim was actually evaluated or made by the AI response; the content is primarily about label-excerpt availability and inability to assess without a specific claim.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Medium

Recommendation

Insufficient Information

Primary Issue
No specific AI medical claim text was provided to compare against the FDA label.

Suggested Improvement
Provide the exact claim(s) from the AI response (verbatim) and the specific label excerpts/sections intended to be evaluated; then score support/contradiction/omission for each claim.